What they were paid
Verve Therapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | $52,500 | $0 | $468,999 | $0 | $521,499 |
| FY2022 | $22,417 | — | $297,813 | — | $320,230 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Verve Therapeutics, Inc. DEF 14A filed April 25, 2025, accession 0000950170-25-058325, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Verve Therapeutics, Inc. filed document, accession 0000950170-25-058325. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2025.
That is Alexander Cumbo’s FY2024 figure, as filed. The FY2025 figure the day it is filed: one email, nothing else.
Saved. One email when Alexander Cumbo’s next annual disclosure lands here, with the figure.
One email when Alexander Cumbo’s next annual disclosure is on this page, with the figure. Nothing else is sent.
Get the Verve Therapeutics Board Governance Report
$521,499 Alexander Cumbo, FY2024 total director compensation
$499
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 25, 2025 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2024Verve Therapeutics pays directors a $45,000 cash retainer and $468,999 in Options.
Committees
FY2024 · as the proxy prints themCompensation
The rest of the Verve Therapeutics board
FY2024 · as the company reported each| Director | Role | FY2024 total |
|---|---|---|
| Burt Adelman, M.D | Chair of the Board | $568,999 |
| Jodie Morrison | Independent Director | $964,970 |
| Krishna Yeshwant, M.D | Independent Director | $522,667 |
| Lonnel Coats | Independent Director | $521,499 |
| Michael MacLean | Independent Director | $533,999 |
| Ourania Tatsis, Ph.D | Director | — |
| Sekar Kathiresan, M.D | Director | — |
| Sheila Mikhail, J.D | Independent Director | $526,499 |
The full Verve Therapeutics compensation record
free company briefThis page is one director within Verve Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Order VERV
Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.